scholarly journals Size-based hydrodynamic rare tumor cell separation in curved microfluidic channels

2013 ◽  
Vol 7 (1) ◽  
pp. 011802 ◽  
Author(s):  
Jiashu Sun ◽  
Chao Liu ◽  
Mengmeng Li ◽  
Jidong Wang ◽  
Yunlei Xianyu ◽  
...  
Lab on a Chip ◽  
2019 ◽  
Vol 19 (1) ◽  
pp. 68-78 ◽  
Author(s):  
Yaoping Liu ◽  
Tingyu Li ◽  
Mingxin Xu ◽  
Wei Zhang ◽  
Yan Xiong ◽  
...  

The developed high-throughput liquid biopsy platform for rare tumor cell separation from body fluids has shown enormous promise in cancer detection and prognosis monitoring.


Author(s):  
Jiashu Sun

We report on the development of a curved microfluidic channel that allows rapid and continuous size-based rare tumor cell separation from blood in a label-free manner by exploiting the hydrodynamic effects. The separated tumor cells are trapped and enriched on an integrated polycarbonate filter glued on top of the outlet reservoir of microchannels. CK19 mRNA of MCF-7 cells are detected by loop-mediated isothermal amplification (LAMP).


Lab on a Chip ◽  
2021 ◽  
Author(s):  
Di Huang ◽  
Nan Xiang

A three-stage i-Mag device combines the passive inertial microfluidics and the active magnetophoresis method for rapid, precise, and tumor antigen-independent separation of rare tumor cells from blood.


1997 ◽  
Vol 19 (12) ◽  
pp. 1239-1246 ◽  
Author(s):  
A Roots-Weiß ◽  
C Papadimitriou ◽  
H Serve ◽  
B Hoppe ◽  
M Koenigsmann ◽  
...  

2020 ◽  
Vol 41 (23) ◽  
pp. 2000-2006
Author(s):  
Yunlin Quan ◽  
Ke Chen ◽  
Nan Xiang ◽  
Zhonghua Ni

Lab on a Chip ◽  
2012 ◽  
Vol 12 (20) ◽  
pp. 3952 ◽  
Author(s):  
Jiashu Sun ◽  
Mengmeng Li ◽  
Chao Liu ◽  
Yi Zhang ◽  
Dingbin Liu ◽  
...  

2020 ◽  
Vol 142 (3) ◽  
Author(s):  
Yuliang Xie ◽  
Zhangming Mao ◽  
Hunter Bachman ◽  
Peng Li ◽  
Peiran Zhang ◽  
...  

Abstract Density and mechanical properties (e.g., compressibility or bulk modulus) are important cellular biophysical markers. As such, developing a method to separate cells directly based on these properties can benefit various applications including biological research, diagnosis, prognosis, and therapeutics. As a potential solution, surface acoustic wave (SAW)-based cell separation has demonstrated advantages in terms of biocompatibility and compact device size. However, most SAW-reliant cell separations are achieved using an entangled effect of density, various mechanical properties, and size. In this work, we demonstrate SAW-based separation of cells/particles based on their density and compressibility, irrespective of their sizes, by manipulating the acoustic properties of the fluidic medium. Using our platform, SAW-based separation is achieved by varying the dimensions of the microfluidic channels, the wavelengths of acoustic signals, and the properties of the fluid media. Our method was applied to separate paraformaldehyde-treated and fresh Hela cells based on differences in mechanical properties; a recovery rate of 85% for fixed cells was achieved. It was also applied to separate red blood cells (RBCs) and white blood cells (WBCs) which have different densities. A recovery rate of 80.5% for WBCs was achieved.


Cells ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 888
Author(s):  
Taiji Kuwata ◽  
Kazue Yoneda ◽  
Masataka Mori ◽  
Masatoshi Kanayama ◽  
Koji Kuroda ◽  
...  

Circulating tumor cell (CTC) is a potentially useful surrogate of micro-metastasis, but detection of rare tumor cells contaminated in a vast majority of normal hematologic cells remains technical challenges. To achieve effective detection of a variety of CTCs, we have developed a novel microfluidic system (CTC-chip) in which any antibody to capture CTCs is easily conjugated. In previous studies, we employed an antibody (clone E-1) against podoplanin that was strongly expressed on mesothelioma cells. The CTC-chip coated by the E-1 antibody (E1-chip) provided a modest sensitivity in detection of CTCs in malignant pleural mesothelioma (MPM). Here, to achieve a higher sensitivity, we employed a novel anti-podoplanin antibody (clone NZ-1.2). In an experimental model, MPM cells with high podoplanin expression were effectively captured with the CTC-chip coated by the NZ-1.2 antibody (NZ1.2-chip). Next, we evaluated CTCs in the peripheral blood sampled from 22 MPM patients using the NZ1.2-chip and the E1-chip. One or more CTCs were detected in 15 patients (68.2%) with the NZ1.2-chip, whereas only in 10 patients (45.5%) with the E1-chip. Of noted, in most (92.3%, 12/13) patients with epithelioid MPM subtype, CTCs were positive with the NZ1.2-chip. The CTC-count detected with the NZ1.2-chip was significantly higher than that with the E1-chip (p = 0.034). The clinical implications of CTCs detected with the NZ1.2-chip will be examined in a future study.


Sign in / Sign up

Export Citation Format

Share Document